Intermediate risk prostate tumors contain lethal subtypes

Intermediate risk prostate tumors contain lethal subtypes

In 2024, prostate cancer (PCa) remains the most common non-skin cancer in males within the United States, with an estimated 299,010 new cases, the highest increase incident trend rate (3.8%) of all cancers, and one of the eight deadliest. PCa cases are projected to double from 1.8 million to 2.9 mil...

Full description

Saved in:
Bibliographic Details
Main Authors: William L. Harryman, James P. Hinton, Rafael Sainz, Jaime M. C. Gard, John M. Ryniawec, Gregory C. Rogers, Noel A. Warfel, Beatrice S. Knudsen, Raymond B. Nagle, Juan J. Chipollini, Benjamin R. Lee, Belinda L. Sun, Anne E. Cress
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Urology
Subjects:
prostate cancer
cribriform
intraductal carcinoma
gleason grade
intermediate risk
biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fruro.2024.1487873/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items